Quest Diagnostics (DGX)
(Delayed Data from NYSE)
$146.01 USD
-0.83 (-0.57%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $143.59 -2.42 (-1.66%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth A Momentum B VGM
Industry / Sector Report
Industry : Medical - Outpatient and Home Healthcare
Zacks Industry Rank
Top 25% (63 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.33 | 1.68 | 9.99 |
Current Quarter Estimate | 2.31 | 0.69 | 61.00 |
Year Ago Quarter Estimate | 2.30 | 1.31 | 54.84 |
Next Quarter Estimate | 2.31 | 0.72 | 63.00 |
Next Year Estimate | 9.50 | 5.93 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 1.61 | 14.40 | 15.67 |
Next Year | 7.34 | 13.00 | 9.31 |
Last 5 Years | 7.40 | 4.20 | 8.10 |
Next 5 Years | 5.20 | 12.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 16.76 | 13.83 |
Price/Book (MRQ) | 2.51 | 2.77 |
Price/Cash Flow (MRFY) | 11.46 | 14.44 |
Dividend Yield | 2.05% | 0.00% |
Net Profit Margin (TTM) | 9.11% | NA |
Return on Equity (TTM) | 15.52% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.